Home › Funds › Integral Health Asset Management, LLC › ROIV

Integral Health Asset Management, LLC position in ROIV

ROIVANT SCIENCES LTD · Health Care

Integral Health Asset Management, LLC reported holding 2,000,000 shares of ROIV (ROIVANT SCIENCES LTD) in its Q3 2026 13F filing — a position valued at US$18.3M, representing 1.19% of its reported portfolio and ranking #25 among its reported holdings. Integral Health Asset Management, LLC has disclosed ROIV holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.00M sh
Reported value held$18.29M
Portfolio Weight1.19%
First reportedQ3 2023
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Integral Health Asset Management, LLC's ROIV position evolved

Integral Health Asset Management, LLC first disclosed a stake in ROIV in Q3 2023 at 450,000 shares (US$5.3M). The position peaked in Q2 2026 at 2,000,000 shares, worth US$70.8M. Across 10 filings, Integral Health Asset Management, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 2,000,000 shares valued at US$18.3M. Notable position changes include a 33% trim in Q2 2024 (shares rose 9% over the following quarter), a 25% increase in Q3 2025 (shares rose 43% over the following quarter), a 135% increase in Q1 2026 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 450.00K $5.26M New
Q1 2024 600.00K $6.32M New
Q2 2024 400.00K $4.23M Reduce
Q1 2025 600.00K $6.05M New
Q2 2025 600.00K $6.76M Hold
Q3 2025 750.00K $11.35M Add
Q4 2025 850.00K $18.45M Add
Q1 2026 2.00M $55.40M Add
Q2 2026 2.00M $70.78M Hold
Q3 2026 2.00M $18.29M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ROIV and 13F data

ROIV (ROIVANT SCIENCES LTD) is a Health Care company. 57 other funds we track also report a position in ROIV — the largest reported positions include QVT Financial LP (US$839.6M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$795.2M), Farallon Capital Management (US$506.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ROIV

All ROIV fund holders →

FAQ

How long has Integral Health Asset Management, LLC held ROIV?

Integral Health Asset Management, LLC has disclosed ROIV holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

What is Integral Health Asset Management, LLC's current position in ROIV?

As of Q3 2026, Integral Health Asset Management, LLC holds 2.00M shares of ROIV (ROIVANT SCIENCES LTD), valued at $18.29M, representing 1.19% of its reported portfolio and ranking #25.

Has Integral Health Asset Management, LLC been buying or selling ROIV?

In the latest 13F filing (Q3 2026), Integral Health Asset Management, LLC held unchanged its position in ROIV. The position peaked in Q2 2026 at 2.00M shares.

Which other funds hold ROIV?

Other major institutional holders of ROIV include QVT Financial LP, FARALLON CAPITAL MANAGEMENT, L.L.C., Farallon Capital Management, among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.